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TeenagersIntroduction: Adipose tissue distribution is effective in metabolic complications resulting from obesity.
The present study aimed to determine the prevalence of obesity and android obesity based on various
phenotypes of Polycystic Ovarian Syndrome (PCOS) in 14–18 year old high-school female students in
Shiraz in 2009.
Methods: This descriptive study was conducted on 14–18 years old high-school girl in Shiraz in 2009.
3190-Subject sample size was determined. After obtaining written informed consents, demographic
information questionnaire was completed and the participants were examined regarding hirsutism, acne,
alopecia, and menstrual disorders. Besides, the criteria proposed by Adams et al. were employed to diag-
nose PCOS in sonography. Android obesity and BMI were evaluated. Then, the data were entered into the
SPSS software (v. 11.5) and analyzed.
Results: The participants’ mean weight, mean height, and mean waist circumference were
54.14 ± 9.99 kg, 160.20 ± 5.76 cm, and 65.24 ± 7.34 cm, respectively. In addition, 616 participants
(20.5%) were underweight, 234 (9.5%) were overweight, and 110 (3.5%) were obese. Also, 15 participants
(0.5%) had android obesity. The results of independent t-test showed no significant difference among var-
ious phenotypes of PCOS regarding mean android obesity and BMI (P > 0.05). Overall, 16.6% of the study
participants (514 subjects) suffered from menstrual disorders and oligomenorrhea. Also, 99 participants
(3.1%) had BMIP 26.
Conclusion: The results revealed no significant relationship between female adolescents’ obesity and
various phenotypes of PCOS. However, adolescents should be informed about the long-term hyperandro-
genic outcomes which are accompanied by insulin secretion and endanger their health after the age of
40 years.
 2015 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In Europe, Polycystic Ovarian Syndrome (PCOS) is diagnosed by
existence of cystic ovaries in sonography together with oligomen-
orrhea, hyperandrogenism, obesity, or increase of serum LH or
testosterone. In the U.S., on the other hand, National Institute
Health (NIH) in 1990 suggested hyperandrogenism or hyperandro-
genemia and ovulatory dysfunction in the absence of non-classical
adrenal hyperplasia as the diagnostic criteria for PCOS (Balen et al.,
1995). PCOS is mainly accompanied by oligomenorrhea or amenor-
rhea and is identified by the clinical or laboratory indications ofhyperandrogenemia. Therefore, the prevalence rate of PCOS varies
from 6% to 22% in different parts of the world (March et al., 2010;
Najem, Elmehdawi, & Swalem, 2008) and the difference in statis-
tics results from different criteria used for diagnosis of this syn-
drome (Okan Yildiz, Bozdag, Yapici, Esinler, & Yarali, 2012).
Nowadays, it has been shown that a large number of obese women
with PCOS suffer from hyperinsulinemia, as well (Breek, 2012).
Moreover, many adolescents suffering from PCOS are overweight
or obese. It seems that PCOS is the endocrine cause of obesity in
female adolescents (In-Iw & Biro, 2011). Recent systematic studies
have shown that PCOS can result from the same genetic factors
which lead to obesity in women (Glueck, Papanna, Wang,
Goldenberg, & Sieve-Smith, 2003). The high familial incidence of
the disease suggests its genetic origin, but there is limited
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Moran, 2012). Yet, it is not known whether obesity is the primary
factor in the incidence of PCOS or vice versa. Overall, the women
with PCOS are more obese abdominally compared to those with
similar weight and Body Mass Index (BMI) Lim et al., 2012. Even
non-obese PCOS adolescents have twice as much abdominal fat
as the general population (Ibanes & de Zegher, 2004). Android obe-
sity is highly correlated to hyperandrogenism and BMI is correlated
to insulin resistance and cardiovascular disease (Baer, Milliren,
Walls, & DiVasta, 2014).
The results of the study by Trent, Rich, Austin, and Gordon
(2002) showed that weight problems caused stress and anxiety
for the individuals suffering from PCOS. Hence, psychological prob-
lems and difficulty in determining one’s health and identity is
another important dimension of this syndrome. Evidence has
shown that adult females with PCOS normally suffer from infertil-
ity and its outcomes, while such adolescents are more concerned
with weight gain, menstrual disorders, acne, and hirsutism. These
complications seriously affect the young girls’ quality of life.
Therefore, young adults suffering from this syndrome must be
diagnosed and treated as soon as possible.2. Materials and methods
This descriptive study was conducted on 14–18 year old high-
school female students in Shiraz in 2009. Based on a similar study
performed in Isfahan (Fatemi Naeini, Najafian, & Jazebi, 2012) and
considering the confidence coefficient of 95% and loss rate of 20%, a
3190-subject sample size was determined for the study. To reduce
the costs and increase the coverage, we used cluster sampling.
Shiraz has four educational districts, so 600–800 students were
selected from each district. Then we used purposive sampling
method to select students in each school. The inclusion criteria of
the study were being 14–18 years old and not consuming any hor-
mones and medications except for anti-allergy and analgesic drugs.
On the other hand, the exclusion criteria of the study were passage
of less than 2 years from menarche, having adrenal or thyroid
problems, suffering from hyperprolactinemia, primary amenor-
rhea, serious underlying diseases, such as malignancies and tha-
lassemia, which affect menstrual cycles, and having identified
endocrinopathies, such as Cushing syndrome.
After obtaining written informed consents, demographic infor-
mation questionnaire was completed and the participants were
examined regarding hirsutism, acne, alopecia, and menstrual dis-
orders. Besides, the criteria proposed by Adams et al. were utilized
to diagnose PCOS in sonography (observing multiple cysts 10 or
more with 2–8 mm diameter in the ovary and increasing ovarian
stroma) (Adams, Polson, & Franks, 1986). The participants’ waist
circumference was measured as the distance between the last rib
and the iliac crest at the end of expiration in standing position.
In order to determine android obesity, based on waist circumfer-
ence and age, percentilesP90 were considered as android obesity
(Dunaif, Segal, Futter Weit, & Dobrjansky, 1989; Malekzadeh,
Mohammadnejad, Merat, Pourshams, & Etemad, 2006).
In order to compute BMI, at first, the participants’ height was
measured without shoes using a tape meter installed on the wall
40 cm higher than the ground level. In doing so, the participants
were asked to stick their back of the head, waist, hip, and feet to
the wall and their height was determined by placing a ruler on
their head. Then, the participants’ weight was measured barefoot
with the least amount of clothing using CAMRY scale (made in
China) which was previously adjusted by standard weights
(Rashidi & Payami, 2014).
BMI charts provided by the Center for Disease Control (CDC)
were used to determine underweight, overweight, and obesity.Accordingly, 85–95 percentiles were considered as overweight,
while percentiles P95 were considered as obese (Malekzadeh
et al., 2006). After all, the data were entered into the SPSS statisti-
cal software (version 11.5) and analyzed using Chi-square test.3. Results
Out of the 41 governmental high schools in Shiraz, 16 took part
in the present study. The study was conducted on 3190
high-school female students between 14 and 18 years old in
Shiraz. According to the results, most of the participants (30.2%)
were 17 years old. The participants’ mean weight, mean height,
and mean waist circumference were 54.14 ± 9.99 kg,
160.20 ± 5.76 cm, and 65.24 ± 7.34 cm, respectively. In addition,
616 participants (20.5%) were underweight, 234 (9.5%) were over-
weight, and 110 (3.5%) were obese. Also, 15 participants (0.5%) had
android obesity.
The results of independent t-test revealed no significant differ-
ence between the phenotypes of the participants with hyperandro-
genism and PCOS and those without these disorders; phenotypes
of the participants with oligomenorrhea and PCOS and those not
suffering from these disorders (P = 0.41); and phenotypes of the
participants with oligomenorrhea, PCOS, and hyperandrogenism
and those without these disorders concerning the mean of android
obesity and BMI (P = 0.5).
Overall, 16.6% of the study participants (514 subjects) suffered
from menstrual disorders and oligomenorrhea. Also, 99 partici-
pants (3.1%) had BMIP 26.4. Discussion
The results of the present study showed that the prevalence
rates of overweight and obesity in Shiraz were similar to those
reported in developed countries and other parts of Iran. The preva-
lence of obesity is more pronounced than that of thinness in school
children and adolescents in Shiraz. Therefore, preventive measures
for controlling obesity are a must for public health promotion
among school children in Iran (Ayatollahi, Bagheri, & Heydari,
2013).
For instance, Salem and Vazirinejad (2007) conducted a study
on 11–18 year old girls in Rafsanjan and reported the prevalence
rates of overweight and obesity to be 11.2% and 2.4%, respectively
(Salem & Vazirinejad, 2007). In the present study, 9.5% of the
participants were overweight and 3.5% were obese. One study per-
formed in the U.S. also showed that 16.8% of 2–19 year old girls
were obese (Ogden, Carroll, Kit, & Flegal, 2012). In another study
conducted in Greece, the prevalence rates of overweight and
obesity were 19% and 2.6%, respectively among 11–17 year old
adolescents and these rates were higher among males compared
to females (Krassas, Tzotzas, Tsametic, et al., 2001). The prevalence
of obesity is also high in developing countries. In India, for
example, the prevalence rates of overweight and obesity among
9–15 year old children have been reported to be 11.1% and 14.2%,
respectively (Chhatwal, Verma, & Riar, 2004). Hekimsoy and
Oktern (2003) mentioned obesity as an important risk factor of
type II diabetes, arterial hypertension, and hyperlipidemia.
However, contradictory results have been obtained regarding the
relationship between duration of obesity and these risks
(Hekimsoy and, Oktern, 2003). Thus, obesity has been considered
as a major problem for girls’ health in future.
In the current study, the prevalence of android obesity was 0.5%
which was lower compared to the measures obtained in the stud-
ies performed by Salem and Halley Castillo et al. (2007). In spite of
the fact that the prevalence rate of android obesity was low in this
study, it is still an alarming issue because according to the studies
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two folds (RR = 2.41, P = 0.04) Okan Yildiz et al., 2012. It can also
increase the incidence rate of metabolic syndrome in future. In fact,
android obesity leads to resistance in consumption of peripheral
glucose and results in hypertension and further metabolic prob-
lems by causing hyperinsulinemia (Pyorala, Miettinen, Laakso, &
Pyorala, 1998). The low prevalence of android obesity in the pre-
sent study might be due to the participants’ age and sex. These
results are similar to those of Rahmanpour et al. in Zanjan
(Rahmanpour, Heidari, Mousavinasab, Sharifi, & Fekri, 2008). In
fact, female teenagers are highly concerned with android obesity.
The results of this study also indicated that the prevalence rates
of obesity and android obesity were higher in some phenotypes of
PCOS. However, no significant difference was observed between
the PCOS patients and those not suffering from this syndrome in
this regard. Of course, this was not unexpected because based on
the recent systematic review studies conducted on this issue, Asian
women are less obese compared to the Caucasian women suffering
from PCOS (Breek, 2012). Thus, the incidence of PCOS might also be
associated with racial factors. Yet, other studies have indicated that
almost 25–50% of the women with PCOS are obese (Azziz, 2003;
Buggc & Rosenfield, 2005). These measures have been reported
as 10–65% in some studies. Also, a large number of adolescents suf-
fering from PCOS are either overweight or obese. In fact, PCOS is
the most common endocrine cause of obesity in adolescents
(Christopher, Mc Cartney, & Kathleen, 2005). In one study, the
prevalence of obesity was reported as 27% among the adolescents
with PCOS (Buggc & Rosenfield, 2005). Normal weight girls with
PCOS are probably a part of a continuous spectrum of clinical PCOS
rather than a distinct entity. (McManus, Levitsky, & Misra, 2013).
The findings of the present study revealed no significant rela-
tionship between BMI and menstrual patterns. In this study, out
of the 16.6% of the participants with menstrual disorders, 3.1%
(99) were overweight or obese. Evidence has shown that the indi-
viduals with oligomenorrhea have higher BMI. Csermely et al.
(2002) also reported high BMI in 19 girls between 16 and 18 years
of age who suffered from oligomenorrhea. Since obesity increases
the androgen levels, it is usually accompanied by PCOS and
oligomenorrhea. Furthermore, irregular and long menstrual cycles
might have genetic background, as well. Nevertheless, the differ-
ence between the results of the present study and those of other
studies conducted on the issue might be due to the adolescents’
nutritional status and their great concern for appropriate waist
and hip circumference. Of course, since individuals genetically
have the disorder, its symptoms are intensified by environmental
factors and individuals’ lifestyles. BMI is one of the main environ-
mental factors which can intensify or reduce the severity of the
disorder (Balen et al., 1995; Csermely et al., 2002; Dramusic
et al., 1997; Homburg & Lambalk, 2004; Teede, Deeks, Moran, &
Peovielwy, 2010).
5. Conclusion
The results of the present study revealed no significant differ-
ence between Iranian female adolescents and those in developed
countries regarding the prevalence of obesity. This is an alarming
issue for the related health organizations. Thus, appropriate educa-
tional and social strategies including motivation to do sports activ-
ities, getting serious high school sports time, high school specific
times for sports, accurate information on the use of healthy snacks
in schools and to facilitate admission to sports clubs can be helpful
in reducing obesity. Health education programs are implemented;
they are effective for prevention of overweight girls. Besides the
choice of a non-obese peer also helped the teens to go on a diet.
The implementation of the above suggestions should be consid-
ered in preventing this problem, because overweight can lead tometabolic syndrome and PCOS which are serious threats for health.
Moreover, adolescents should be informed about the long-term
hyperandrogenic outcomes which are accompanied by insulin
secretion and endanger their health after the age of 40 years. The
study findings also indicated that various phenotypes of PCOS in
adolescents were not significantly related to obesity and over-
weight. Therefore, further studies are required to investigate the
psychological and genetic causes of the incidence of this syndrome.Conflict of interest
None.
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